 DELRAY BEACH, Fla., Jan. 06, 2021 GLOBE NEWSWIRE -- AzurRx BioPharma, Inc. NASDAQ: AZRX, AzurRx or the Company, a company specializing in the development of targeted, non-systemic therapies for gastrointestinal GI diseases, today announced that the Company will be participating in the virtual H.C. Wainwright BioConnect 2021 Conference. 